About 100 reports

  • Gastrointestinal Drugs Market Competitive Landscape
  • Gastrointestinal Drugs Market Trends And Strategies

The gastrointestinal diseases drugs market covers medicines used for the treatment of ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors,...

  • Gastrointestinal Drug
  • World
  • Market Size
  • Allergan plc
  • Novo Nordisk Group

Gastrointestinal Drugs Global Market Report 2018 ##.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL
  • GASTROINTESTINAL THERAPEUTICS MARKET, GLOBAL, APPROVED GASTROINTESTINAL

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Gastrointestinal Drug
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited

The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of block-busters.

  • Gastrointestinal Drug
  • OTC
  • World

Segments Covered ##) Global Gastrointestinal Drugs market a.

  • Gastrointestinal Drug
  • OTC
  • World
  • Market Size
  • 07. Epidemiology of Gastrointestinal Disorders
  • GLOBAL GASTROINTESTINAL OTC DRUGS MARKET BY THERAPEUTIC CLASS OF DRUG

About gastrointestinal OTC drugs OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal...

  • Gastrointestinal Drug
  • World
  • GlaxoSmithKline plc
  • Perrigo Company
  • Pfizer Inc.
  • GASTROINTESTINAL DRUGS
  • Global Gastrointestinal Drugs Market, Segmentation By Subsegment

The global pharmaceutical drug market was worth $934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth $1,170.4 billion by 2021. Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma...

  • Gastrointestinal Drug
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Zantac
  • RECENT DEVELOPMENTS

Safe if provided warnings are followed ##.

  • Gastrointestinal Drug
  • AstraZeneca PLC
  • Eisai Co., Ltd.
  • Johnson & Johnson
  • Takeda Pharmaceutical Company Limited
  • ABBREVIATIONS

Patients will be randomized (##:##) to MSB-## or placebo for one week.

  • Dermatological Condition
  • Gastrointestinal Drug
  • Therapy
  • United States
  • Synthetic Biologics
  • Market definition
  • EMEA - MARKET SIZE AND FORECAST 2017-2022

You can easily book an appointment with one online.

  • Gastrointestinal Drug
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • SAFETY OF LOTRONEX - MOST FREQUENTLY REPORTED AES
  • PRODUCT PROFILE - SYN-010

Our Gastrointestinal Portfolio.

  • Gastrointestinal Drug
  • Allergan plc
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.
  • Other gastrointestinal disease, total (000s)
  • IBS patients with gastroenteritis, total (000s)

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Irritable Bowel Syndrome in 12 Major Markets Irritable Bowel Syndrome (IBS) is a functional bowel disorder which incorporates a group of symptoms but includes abdominal pain and disturbed defecation. IBS is divided into several subtypes including: • Diarrhoea predominant...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Pathology
  • Italy
  • FAMOTIDINE, LANSOPRAZOLE AND TRANEXAMIC ACID ALONE OR IN COMBINATION HAVE THE HIGHEST NUMBER OF GASTROINTESTINAL BLEEDING (GASTROINTESTINAL HEMORRHAGE) ONGOING CLINICAL TRIALS.
  • Clinical Trial profile. 77 Trial Title

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage)...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Therapy
  • World
  • Product Initiative
  • 2. H2 RECEPTOR ANTAGONISTS
  • Digestive Remedies Market Overview

The demand for Bismuth preparation is limited due to its poor taste. (##)Sucralfate is an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.

  • Gastrointestinal Drug
  • China
  • Demand
  • Trade
  • AstraZeneca PLC
  • Irritable Bowel Syndrome: Executive Summary
  • 3.1 DISEASE BACKGROUND

Gut and Liver; ##(##):##-##.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • Italy
  • Forecast
  • CHAPTER IV DIGESTIVE REMEDIES DRUGS PRODUCTION AND DEMAND

The demand for Bismuth preparation is limited due to its poor taste. (##)Sucralfate is an oral gastrointestinal medication primarily indicated for the treatment of active duodenal ulcers.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • APAC
  • North America
  • World
  • Forecast
  • Regional Sales of Gluten-Free Food 2012/2017/2022
  • Digestive Remedies Sales by Region: 2012/2017/2022

Japan and South Korea saw declines in sales over the same time period, with CAGRs of -##% and - ##%, respectively, while India only saw an increase of ##% over that time.

  • Gastrointestinal Drug
  • Demand
  • Bayer AG
  • Pfizer Inc.
  • Sanofi S.A.
  • PROPORTION OF REFLUX ESOPHAGITIS (GASTROESOPHAGEAL REFLUX DISEASE) TO GASTROINTESTINAL CLINICAL TRIALS, G7 COUNTRIES
  • Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials...

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Gastrointestinal infection
  • Proportion of Diarrhea to Gastrointestinal Clinical Trials, G7 Countries (%), 2015*

Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial...

  • Gastrointestinal Drug
  • North America
  • United States
  • World
  • Furiex Pharmaceuticals, Inc.

FOLLOWED TYPES ARE THE GASTROINTESTINAL TRACT TYPE, SKIN TYPE OTC DRUGS.

  • Gastrointestinal Drug
  • China
  • Demand
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Patient Details
  • Drug Details

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Other Adverse Events
  • Drug Details

The prominent features of this report are - ##.

  • Gastrointestinal Drug
  • World
  • AstraZeneca PLC
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Tianjin Pharmaceutical Co., Ltd.

The auto exports exceeded over ## million each year.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Gastrointestinal Drugs
  • Six: Gastrointestinal Drugs

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Gastrointestinal Drug
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

They have sixty plus products on market, covering categories of gastrointestinal, cardiovascular, anti-tumor, and antibiotics.

  • Gastrointestinal Drug
  • China
  • Demand
  • AstraZeneca PLC
  • Xian-Janssen Pharmaceutical Ltd.

The largest deal was the $##, ##m research, development, collaboration, and license agreement in January 2017 between Allergan and Assembly Biosciences for the worldwide rights to Assembly’s microbiome gastrointestinal development programs.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • OTC
  • United States
  • World
  • Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015*
  • Clinical Trials by G7 Countries: Proportion of Irritable Bowel Syndrome to Gastrointestinal Clinical Trials

Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Irritable Bowel Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical...

  • Drug Discovery And Development
  • Gastrointestinal Drug
  • United States
  • World
  • Salix Pharmaceuticals, Ltd.

There are many small producers whose capacity is below one billion yuan.

  • Gastrointestinal Drug
  • China
  • AstraZeneca China Inc.
  • Eisai Co., Ltd.
  • Nanjing Aosaikang Medicinal Group